You are here

Inotuzumab Ozogamicin - PF-05208773

Last updated on November 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

-

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

-

NCT03127605
Pfizer
Available
Inotuzumab Ozogamicin - PF-05208773

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Descriptive Information
Brief TitleInotuzumab Ozogamicin - PF-05208773
Official TitleNot Provided
Brief Summary

Information relating to requesting compassionate access for this investigational drug can be found at the following link:

http://www.pfizer.com/research/compassionate_use

Detailed DescriptionNot Provided
Study TypeExpanded Access
Expanded Access TypeIndividual Patients
ConditionNot Provided
InterventionDrug: Inotuzumab Ozogamicin
Other Name: PF-05208773
Publications *Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Expanded Access StatusAvailable
Eligibility Criteria

Inclusion Criteria:

-

Exclusion Criteria:

-

Sex/GenderNot Provided
AgesChild, Adult, Older Adult
Contacts
Contact: Pfizer CAReS1-800-718-1021[email protected]
Listed Location CountriesNot Provided
Removed Location Countries  
 
Administrative Information
NCT NumberNCT03127605
Other Study ID NumbersB193
Responsible PartyPfizer
Study SponsorPfizer
CollaboratorsNot Provided
InvestigatorsNot Provided
PRS AccountPfizer
Verification DateSeptember 2019

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now